Breathe Well Live Well
|
Asthma Tied to Increased Risk of Chronic Migraines
Monthly Prescribing Reference (registration) (HealthDay News) — People with asthma may be more than twice as likely to develop chronic migraines as those without asthma, according to a study published online November 19 in Headache. The research included 4 446 Americans. At the start of the … |
View full post on asthma – Google News
The Pharma Letter (registration) |
GSK gets European marketing rights for Nucala to treat asthma
The Pharma Letter (registration) UK drug major GlaxoSmithKline (LSE: GSK) said the European Commission has granted marketing rights for its drug Nucala (mepolizumab) as an add-on treatment for asthma. Nucala is now approved for use in the 31 European countries covered by the … EU OK for GSK's novel asthma biologic Nucala Now Available for Severe Asthma EU Grants Marketing Authorization to GSK's Nucala |
View full post on asthma – Google News
Monthly Prescribing Reference (registration) |
Nucala Now Available for Severe Asthma
Monthly Prescribing Reference (registration) GlaxoSmithKline announced the launch of Nucala (mepolizumab) subcutaneous injection for the treatment of patients aged ?12 years with severe asthma with an eosinophilic phenotype. Nucala, the first biologic add-on therapy approved for this condition, … GSK Announces NucalaB. (mepolizumab), Now Available In The Us For Sub-Group Of … GSK Says Nucala Available In U.S. For Sub-group Of Patients With Severe Asthma |
View full post on asthma – Google News
Xconomy |
GSK, Propeller Health partner to study smart inhalers for asthma, COPD drugs
FierceMedicalDevices (press release) (registration) Fierce 15 company Propeller Health has announced an R&D collaboration with GlaxoSmithKline ($GSK), under which it will design and manufacture a custom sensor for the Ellipta inhaler to be used in GSK clinical studies of asthma and COPD. The goal is to … GSK, Propeller Health Ink R&D Deal For Custom Respiratory Device Propeller Health Announces Development Agreement and R&D Collaboration with … Propeller Health, GSK to Develop Digital Sensor for Ellipta® Inhaler |
View full post on asthma – Google News
|
Can Vitamin D Supplementation Help Cut Colds in Asthma?
Monthly Prescribing Reference (registration) (HealthDay News) — Vitamin D supplementation does not reduce cold severity or frequency among adults with mild-to-moderate asthma, according to a study published online Nov. 5 in the American Journal of Respiratory and Critical Care Medicine. |
View full post on asthma – Google News
|
Substantial Increase in Costs for Uncontrolled Asthma
Monthly Prescribing Reference (registration) (HealthDay News) — A considerable proportion of patients with mild to moderate asthma are symptomatically uncontrolled, and uncontrolled asthma is associated with significantly increased costs, according to a study published online Nov. 3 in Allergy. |
View full post on asthma – Google News
Food World News |
Asthma Med Step Down Can Be Safe, Cost-Effective
Monthly Prescribing Reference (registration) According to a study in The Journal of Allergy and Clinical Immunology, stepping down asthma medications can be done safely and at less cost. In order to better understand the risks related to the right time in stepping down daily asthma therapy … Should 4-month-old Babies Eat Solid? |
View full post on asthma – Google News
|
Asthma Linked to Increased Risk of Parkinson's Disease
Monthly Prescribing Reference (registration) Chih-Ming Cheng, MD, from the Taipei Veterans General Hospital in Taiwan, and colleagues examined the temporal association between asthma and Parkinson's disease. A cohort of 10,455 patients (age ?45 years) who were diagnosed with asthma … |
View full post on asthma – Google News
Monthly Prescribing Reference (registration) |
Non-Adherence to Asthma Tx a Growing Problem
Monthly Prescribing Reference (registration) An analysis published in the Journal of Clinical Pharmacy and Therapeutics of asthma medication adherence showed poor coverage across a six-month period. Researchers from the University of Utah and colleagues conducted a study to assess the level of … |
View full post on asthma – Google News
|
Boston Scientific faces reimbursement hurdles for lung-searing asthma …
FierceMedicalDevices (press release) (registration) Boston Scientific ($BSX) had high hopes for its electrode-tipped catheter treatment for asthma after snatching up the system in 2010 through its $193.5 million purchase of Asthmatx. But the company is hitting a wall with the product as insurers … |
View full post on asthma – Google News